Edaravone Dexborneol placebo

DRUG2 trials

Sponsors

Beijing Tiantan Hospital, Xiangya Hospital of Central South University

Conditions

Acute Ischemic StrokeEdaravone DexborneolIschemic Stroke, AcuteMechanical ThrombectomyPhase IIITreatment Outcome

Phase 3

Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)

CompletedNCT05249920

Beijing Tiantan HospitalAcute Ischemic Stroke, Edaravone Dexborneol, Mechanical Thrombectomy +1

Start: 2022-03-18End: 2023-05-19Updated: 2023-08-22

Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke

Xiangya Hospital of Central South UniversityIschemic Stroke, Acute, Treatment Outcome

Start: 2023-07-01End: 2024-12-31Target: 212Updated: 2023-06-27

Related Papers

Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial.

2026-01-07